ALTEOGEN Beheer
Beheer criteriumcontroles 1/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Soon-Jae Park
Algemeen directeur
n/a
Totale compensatie
| Percentage CEO-salaris | n/a |
| Dienstverband CEO | no data |
| Eigendom CEO | 19.7% |
| Management gemiddelde ambtstermijn | 2.8yrs |
| Gemiddelde ambtstermijn bestuur | geen gegevens |
Recente managementupdates
Geen updates
Recent updates
ALTEOGEN's (KOSDAQ:196170) Shareholders Should Assess Earnings With Caution
May 25
ALTEOGEN (KOSDAQ:196170) Has Debt But No Earnings; Should You Worry?
Feb 29ALTEOGEN Inc.'s (KOSDAQ:196170) Has Found A Path To Profitability
Apr 13Is Weakness In ALTEOGEN Inc. (KOSDAQ:196170) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Feb 18
Do Insiders Own Lots Of Shares In ALTEOGEN Inc. (KOSDAQ:196170)?
Dec 27CEO
Soon-Jae Park
no data
Tenure
Dr. Soon-Jae Park, Ph D., serves as the Chief Executive Officer of ALTEOGEN Inc. He has several years of experience in R&D of biomedicine. He served as the Executive Officer at BINEX Co., Ltd.He started w...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chief Executive Officer | no data | geen gegevens | 19.67% ₩ 3.1t | |
| CFO & Executive VP | 2.8yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Management Support Group | 2.8yrs | geen gegevens | geen gegevens | |
| Executive VP & Corporate Alliance Officer (CAO) | 4.8yrs | geen gegevens | geen gegevens | |
| Senior VP & Head of New Drug Development | no data | geen gegevens | geen gegevens | |
| Chief Business Development Officer | 2.8yrs | geen gegevens | geen gegevens |
2.8yrs
Gemiddelde duur
Ervaren management: Het managementteam van A196170 wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.8 jaar).